Market intel9 min read·EN

DUH: Inside the H1 2026 banking engine, deep valuation disconnect, and Donev's market accumulation

Doverie United Holding's H1 2026 numbers reveal a banking-led group trading below 2x earnings, just as a board-linked vehicle absorbs a striking share of BSE liquidity.

Published Updated

Doverie United Holding (BSE: DUH) continues to trade under the legacy perception of a sprawling, post-privatization industrial conglomerate. Yet its actual financial reporting reveals a vastly different animal: DUH functions economically as a regional financial-services powerhouse, anchored by Moldovan banking and supported by dependable domestic cash flows from Bulgarian DIY retail and private healthcare.

At €7.12 per share and a market capitalization of approximately €150m–€153m, the company sits at a valuation discount that looks increasingly disconnected from its underlying earnings power. In September 2026, this fundamental dislocation met a potent technical catalyst: Donev Investments Holding AD stepped into the market, systematically absorbing liquidity across the Bulgarian Stock Exchange (BSE) order book.

The operating reality: Moldovan banking and Bulgarian cash flow

DUH's interim consolidated financial statements for H1 2026 show total group revenue reaching €184.47m. Rather than a fragmented collection of industrial operations, the group's economic center of gravity is concentrated in two primary engines:

  • •The dominant profit engine — Moldindconbank S.A., 78.21% owned: Financial services generated €114.15m, representing 61.9% of total group turnover. The performance was anchored by €76.92m in interest income, up 21.1% year on year, and €26.69m in fee and commission income.
  • •The Bulgarian operational core: Non-banking activities delivered €70.32m, or 38.1% of revenue. Crucially, this is not a scattered industrial portfolio; it is concentrated in DIY retail via Doverie-Brico at €58.14m, or 82.7% of non-banking sales, and healthcare services via MBAL/MC Doverie at €10.31m, or 14.7%. Secondary activities such as wine at €1.11m and construction materials at €0.72m are negligible in the overall mix.

For H1 2026, consolidated net profit reached €45.35m, up 1.7% year on year, with €37.36m attributable to parent equity holders, even after booking €3.41m in banking impairment charges.

Profitability quality: strong return metrics with an owner-earnings nuance

DUH's historical profitability across 2023–2025 demonstrates significant operating leverage, though disciplined investors should take note of cash-conversion dynamics:

Profitability metric2023 FY2024 FY2025 FYH1 2026 proxyTakeaway
ROE, attributable19.6%17.6%23.6%—Driven by expanding equity, from €199.4m to €287.3m, not financial engineering
Consolidated net margin16.2%16.3%22.4%—Surpassed the 20% mark on favorable banking spreads
ROIC, proxy~18.1%17.6%20.4%—High returns across total invested equity and debt
Gross margin, non-bankingn/an/an/a44.5%Healthy pricing power in retail and private healthcare
Attributable net income€35.7m€39.4m€62.9m€37.4m76% accounting-profit growth between 2023 and 2025
Owner earnings, NI + D&A − CapExn/a€38.8m€32.2m—CapEx surged to €43.7m in 2025, curbing freely distributable cash

While attributable ROE expanded to a high 23.6% in 2025 and book equity grew organically from €199.5m to €287.2m, the cash picture requires context: owner earnings dropped from €38.8m in 2024 to €32.2m in 2025 as CapEx surged. Reported accounting profits currently outpace freely distributable owner cash, reflecting an elevated reinvestment cycle.

The valuation disconnect: below 2x earnings and 0.4x book

Despite posting approximately €78.3m in consolidated profit and ending 2025 with approximately €367.4m in book equity — which climbed to €474.2m by H1 2026 — DUH trades at multiples typical of distressed or non-viable entities:

Valuation metricMultiple / valueImplied valuation context
Share price€7.12BSE closing price on 17 September 2026
Market capitalization~€150m–€153mBased on approximately 21.12m effective shares excluding treasury stock
Trailing P/E~1.9xMarket cap versus 2025 reported profit of €78.3m
Price / book, P/B~0.41xMarket cap versus 2025 equity of €367.4m
Price / FCF~8.1xBased on 2025 proxy FCF of €18.5m
Indicative fair value€7.50–€12.50Central intrinsic case around €10.00 per share

Unpacking the holding discount

Frontier-market equities often face structural headwinds, and DUH is no exception:

  1. 1.Holdco and liquidity discount: Investors historically apply a heavy haircut to diversified holdings where capital extraction and dividend upstreaming are perceived as opaque.
  2. 2.Geopolitical and macro exposure: Moldindconbank operates in Moldova, exposing the group to emerging-market currency fluctuations, regional security risks, and regulatory shifts.
  3. 3.Net interest margin normalization: After NIM peaked at 6.12% in 2023, management reported compression to 5.80% in 2024. However, Moldindconbank largely offset this through balance-sheet expansion: the loan book grew 27.5% year on year, while asset quality improved as the NPL ratio dropped from 7.1% to 5.4%.
  4. 4.Portfolio streamlining: The group has begun shedding non-core assets, notably completing the divestment of insurer OZOF Doverie in February 2025.

Even when factoring in standard conglomerate and frontier-market haircuts, a trailing P/E below 2.0x and a roughly 60% discount to 2025 book value suggest that the market is pricing in severe balance-sheet impairment or trapped capital that the underlying financial data does not support.

The catalyst: aggressive board-linked absorption in September 2026

This wide gulf between intrinsic performance and market pricing offers context for recent insider-related activity. The company's regulatory disclosures under Article 19 of the Market Abuse Regulation show that Donev Investments Holding AD mounted an aggressive open-market buying program in September 2026.

The filings identify the buyer as a legal entity closely associated with Ivan Ognyanov Donev, Executive Director of Donev Investments Holding AD and Deputy Chairman of DUH's Supervisory Board.

Between 1 September and 17 September 2026, Donev Investments Holding acquired 72,900 DUH shares on the BSE. While representing roughly 0.34% of the share base, the execution pattern was striking: repeated direct participation in the continuous market that absorbed a large share of available liquidity on several sessions.

Trade dateDonev purchases, sharesTotal BSE daily volume, sharesDonev share of daily volume
2026-09-013,2004,87665.6%
2026-09-0214,12327,78250.8%
2026-09-031,877n/an/a
2026-09-042,6008,41630.9%
2026-09-083,195n/an/a
2026-09-094059,7144.2%
2026-09-1010,20022,12146.1%
2026-09-1119,40034,45856.3%
2026-09-151,10013,2308.3%
2026-09-1616,55027,48760.2%
2026-09-172505,1074.9%
Total72,900——

On four separate sessions — 1, 2, 11, and 16 September — this single vehicle accounted for 50% to 66% of total market volume. In an illiquid market, bids of this scale provide price support and systematically drain floating supply from the secondary market.

Strategic takeaways for CEE investors

Prior to these transactions, DUH's register was led by Sopharma AD at 20.80%, Telekomplekt AD at 8.92%, and Kaliman-RT AD at 7.66% on an effective share basis excluding treasury stock. Donev Investments Holding was not listed among the greater-than-5% substantial holders, indicating that these trades represent active balance-sheet accumulation rather than mechanical compliance rebalancing.

The investment setup for DUH now pairs two compelling dynamics:

  • •Fundamentally, the group is generating substantial earnings from Moldovan banking operations and core Bulgarian retail, producing an H1 2026 profit of €45.4m and a 2025 attributable ROE of 23.6%, while trading at 0.41x P/B.
  • •Technically and through governance signaling, a vehicle closely associated with a member of DUH's Supervisory Board is actively bidding for stock, taking down more than half of the daily volume on four active sessions.

When a board-linked buyer aggressively absorbs market float at below 2x earnings and less than half of stated book value, the market's conglomerate discount may have stretched far past fundamental justification.

— CEEWire Research Desk

This analysis was created with the help of the CEEWire AI agent, working from the company's regulatory filings and structured XBRL data. For more information about the product or to request a product demo, reach out to [email protected].

TAGS#Doverie United Holding#DUH#BSE#Moldindconbank#Valuation#Insider transactions#H1 2026